featured
Clinical Outcomes and Toxic Effects of Single-Agent ICIs Among Older Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study
JAMA Oncol 2021 Nov 04;[EPub Ahead of Print], CA Nebhan, A Cortellini, W Ma, T Ganta, H Song, F Ye, R Irlmeier, N Debnath, A Saeed, M Radford, A Alahmadi, A Diamond, C Hoimes, N Ramaiya, CJ Presley, DH Owen, S Abou Alaiwi, A Nassar, B Ricciuti, G Lamberti, M Bersanelli, C Casartelli, S Buti, P Marchetti, R Giusti, M Filetti, V Vanella, D Mallardo, S Macherla, TA Sussman, A Botticelli, D Galetta, A Catino, P Pizzutilo, C Genova, MG Dal Bello, F Kalofonou, E Daniels, PA Ascierto, DJ Pinato, TK Choueiri, DB Johnson, TU Marron, Y Wang, AR NaqashFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.